中华病理学杂志最新文献

筛选
英文 中文
[ELOC-mutated renal cell carcinoma with new mutation site combined with lung adenocarcinoma: report of a case]. [新突变位点的 ELOC 突变肾细胞癌合并肺腺癌:一例报告]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20231110-00351
X Q Chen, J Huang, Y Lan, Y L Wu, X C Yan, X W Bian, G J Duan
{"title":"[ELOC-mutated renal cell carcinoma with new mutation site combined with lung adenocarcinoma: report of a case].","authors":"X Q Chen, J Huang, Y Lan, Y L Wu, X C Yan, X W Bian, G J Duan","doi":"10.3760/cma.j.cn112151-20231110-00351","DOIUrl":"10.3760/cma.j.cn112151-20231110-00351","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"861-863"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinicopathological features of BAP1 mutated clear cell renal cell carcinoma]. [BAP1突变透明细胞肾细胞癌的临床病理特征】。]
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20240203-00081
Y F Bai, M H Weng, J J He, L M Xu, C D Chang, X D Teng
{"title":"[Clinicopathological features of BAP1 mutated clear cell renal cell carcinoma].","authors":"Y F Bai, M H Weng, J J He, L M Xu, C D Chang, X D Teng","doi":"10.3760/cma.j.cn112151-20240203-00081","DOIUrl":"10.3760/cma.j.cn112151-20240203-00081","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinicopathological characteristics, immunophenotypes, molecular features, and differential diagnosis of BAP1 mutated clear cell renal cell carcinoma (CCRCC) for better understanding this entity. <b>Methods:</b> Clinical data, histological morphology, immunophenotypes and molecular characteristics of 18 BAP1 mutated CCRCC cases diagnosed at the Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China from January 2020 to December 2022 were analyzed. The patients were followed up. <b>Results:</b> There were 17 males and 1 female patients, aged from 39 to 72 years, with an average age of 56.3 years. Sixteen patients with primary CCRCC were followed up for an average of 24 months, 7 patients had metastases occurred from 4 to 22 months postoperatively. Thirteen of the 16 patients were alive at the time of the last follow-up while 3 patients died 12, 15, and 20 months after the surgery, respectively. One patient underwent retroperitoneal mass resection, but had lung metastasis 32 months after surgery. One case received cervical tumor resection and died at 22 months after the surgery. Characteristic CCRCC regions were identified in 11 of the 18 cases. The tumor cells were arranged in papillary, alveolar, and large nest patterns. Abundant lymphoid tissue, necrosis, and psammoma bodies were seen. Tumor cells showed abundant eosinophilic cytoplasm, and sometimes exhibited rhabdoid differentiation. Round eosinophilic globules were located in the cytoplasm and extracellular matrix. There were 9 cases with WHO/International Society of Urological Pathology grade 3, and 9 cases with grade 4. PAX8 (18/18), carbonic anhydrase 9 (CA9, 16/18), CD10 (18/18), and vimentin (18/18) were positive in the vast majority of tumors.TFE3 was expressed in 5 cases, with strong expression in only 1 case. Eighteen cases were all positive for P504s. Twelve cases harbored a BAP1 mutation combined with von Hippel-Lindau (VHL) mutation, and 2 cases had mutations in BAP1, VHL and PBRM1 simultaneously. SETD2 mutation was not found in any of the cases. <b>Conclusions:</b> BAP1 mutated CCRCC contained papillary, alveolar, and large nest patterns, eosinophilic cytoplasm, high-grade nucleoli, and collagen globules, with P504s positivity. In practical work, when encountering CCRCC containing these features, pathologists should consider the possibility of BAP1 mutations and conduct related molecular tests.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"797-802"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[TFE3-rearranged perivascular epithelioid cell tumors: a clinicopathological analysis of eight cases]. [TFE3重排血管周围上皮样细胞瘤:八例病例的临床病理分析]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20240524-00335
Y Qin, L Yang, H J Zhang, J Wei, Y X Liu, W H Zhang, Z Wen, Z Wang, L N Fan
{"title":"[TFE3-rearranged perivascular epithelioid cell tumors: a clinicopathological analysis of eight cases].","authors":"Y Qin, L Yang, H J Zhang, J Wei, Y X Liu, W H Zhang, Z Wen, Z Wang, L N Fan","doi":"10.3760/cma.j.cn112151-20240524-00335","DOIUrl":"10.3760/cma.j.cn112151-20240524-00335","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinicopathological, immunohistochemical and molecular genetic characteristics of TFE3-rearranged perivascular epithelioid cell tumor (PEComa). <b>Methods:</b> Eight cases of PEComa with TFE3 rearrangement diagnosed in the First Affiliated Hospital of Air Force Medical University from January 2014 to July 2022 were collected. Three were consultation cases and 5 were collected from our hospital; 7 cases were resection specimens and 1 case was a needle biopsy specimen. Routine histolopathological analysis, immunohistochemical staining, fluorescence in situ hybridization (FISH) and the next-generation sequencing were performed. Clinical data were collected and the prognosis was assessed. <b>Results:</b> The 8 patients consisted of 5 females and 3 males with a median age of 45 years (ranged from 25 to 65 years). The tumor location included 1 uterus, 1 liver, 1 urachus, 2 kidneys, 1 abdominal cavity, 1 colon, and 1 retroperitoneum (3 subsequent recurrences in the abdominal cavity, pelvis and ovary, and abdominal cavity, respectively). Morphologically, the tumor cells were uniform and epithelioid with translucent or eosinophilic cytoplasm. They were arranged in nests or sheets, most of which were separated by thin-walled blood vessels. There were no papillary structures, and no overt smooth muscle or fat components. Atypical features were seen in 3 cases, with bizarre nuclei and tumor giant cells. Large areas of necrosis were visible, and mitosis was common (up to 28/50 HPF). Melanin deposition was present in 3 cases. Immunohistochemical staining showed diffuse and strong positivity for TFE3 in 8/8 cases and for HMB45 in 6/8 cases; focal positivity for Cathepsin K and Melan-A in 6/8 cases and for SMA in 2/8 of cases. All cases were negative for CKpan, PAX8 and Desmin. TFE3 gene break-apart was detected by FISH in all 8 cases, 4 of which underwent next-generation sequencing, and it revealed that 2 cases presented with SFPQ::TFE3 fusion, 1 case with ASPSCR1::TFE3 fusion, and 1 case with no chimeric fusion. Seven cases were followed up for 4-94 months. All cases were alive; 4 cases were disease-free, 2 cases showed recurrence, and 1 case had metastasis at initial diagnosis. <b>Conclusions:</b> TFE3-rearranged PEComa has unique histomorphological, immunohistochemical and molecular characteristics. The biological behavior is aggressive, which could lead to recurrence and metastasis, and warrants close clinical follow-up.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"822-829"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Indolent T-cell lymphoma of the gastrointestinal tract with synchronous diffuse large B-cell lymphoma: report of a case]. [胃肠道惰性 T 细胞淋巴瘤伴同步弥漫大 B 细胞淋巴瘤:一例报告]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20240104-00007
L J Chen, X Chu, B B Li, L Li, W S Li
{"title":"[Indolent T-cell lymphoma of the gastrointestinal tract with synchronous diffuse large B-cell lymphoma: report of a case].","authors":"L J Chen, X Chu, B B Li, L Li, W S Li","doi":"10.3760/cma.j.cn112151-20240104-00007","DOIUrl":"10.3760/cma.j.cn112151-20240104-00007","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"870-872"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Embryonal tumor with multilayered rosettes: a clinicopathological analysis of three cases]. [胚胎瘤伴多层玫瑰花瓣:三例病例的临床病理分析]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20240206-00090
L Z Lu, Y X Bai, J Meng, Y Zhang, S G Xie, L H Zhang
{"title":"[Embryonal tumor with multilayered rosettes: a clinicopathological analysis of three cases].","authors":"L Z Lu, Y X Bai, J Meng, Y Zhang, S G Xie, L H Zhang","doi":"10.3760/cma.j.cn112151-20240206-00090","DOIUrl":"10.3760/cma.j.cn112151-20240206-00090","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"849-851"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinicopathological features of tubular cystic renal cell carcinoma]. [肾小管囊性肾细胞癌的临床病理特征]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20231225-00437
W Y Di, K Zhang, J S Li, J Yu, J Li, Y T Li, J H Zhang, X Y Yang, L Sun, W X Zhao, W Su
{"title":"[Clinicopathological features of tubular cystic renal cell carcinoma].","authors":"W Y Di, K Zhang, J S Li, J Yu, J Li, Y T Li, J H Zhang, X Y Yang, L Sun, W X Zhao, W Su","doi":"10.3760/cma.j.cn112151-20231225-00437","DOIUrl":"10.3760/cma.j.cn112151-20231225-00437","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"843-845"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis]. [BRCA2致病基因突变的前列腺癌:临床病理分析]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20240402-00216
D H Wang, W L Yin, X Y Pan, M N Zhang, L Nie, X Q Chen, H Zeng, Q Zhou, N Chen
{"title":"[Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis].","authors":"D H Wang, W L Yin, X Y Pan, M N Zhang, L Nie, X Q Chen, H Zeng, Q Zhou, N Chen","doi":"10.3760/cma.j.cn112151-20240402-00216","DOIUrl":"10.3760/cma.j.cn112151-20240402-00216","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the clinicopathological features of prostate cancers with BRCA2 pathogenic mutations, and the association between BRCA2 pathogenic mutation and clinicopathological characteristics. Patient survivals were also examined. <b>Methods:</b> Clinicopathological data of 249 prostate cancer patients who underwent genetic testing in West China Hospital of Sichuan University, Chengdu, China from June 2014 to August 2021 were collected. A retrospective analysis of histopathological morphology, clinicopathological characteristics, and patient survivals was conducted. <b>Results:</b> The genetic testing in the 249 prostate cancer patients showed a pathogenic mutation of DNA damage repair gene (DRG) in 73 cases (73/249, 29.3%), including 22 cases (8.8%) with BRCA2 pathogenic mutation and 51 cases with pathogenic mutations of other DRG. Among the 22 patients with BRCA2 pathogenic mutation, 14 patients (5.6%) harbored germline mutations and 8 patients (3.2%) somatic mutations. Their ages ranged from 48 to 91 years, with a median of 67 years. Seventeen patients (77.3%) had distant metastasis, including 16 cases with bone metastasis and 1 case with multiple metastases. Thirteen patients (59.1%) were castration-resistant prostate cancer. The histological type was mainly classical prostatic acinar adenocarcinoma, including 16 cases (72.7%) with intraductal carcinoma of the prostate (IDC-P). Six cases (27.3%) showed focal neuroendocrine differentiation. Perineural/vascular invasion and extraprostatic extension were seen in 11 cases (50.0%) and 8 cases (36.4%), respectively. The Gleason scores of 19 patients (86.4%) were≥8. IDC-P was more commonly found in patients with BRCA2 germline pathogenic mutation than those with BRCA2 somatic pathogenic mutation, other DRG pathogenic mutation or no-DRG pathogenic mutation (<i>P</i>=0.002). With a total follow-up time of 189 months, the median overall survival (OS) was 132.3 months. Patients with DRG pathogenic mutation had shorter OS than those with no-DRG pathogenic mutation (<i>P</i>=0.040). The OS of patients with BRCA2 germline pathogenic mutation did not significantly differ from that of patients with BRCA2 somatic pathogenic mutation, other DRG pathogenic mutation or no-DRG pathogenic mutation (<i>P</i>=0.216). <b>Conclusions:</b> The presence of BRCA2 gene pathogenic mutation is common in the prostate cancers with high Gleason grade, advanced clinical stage, and castration resistance. IDC-P is more commonly noted in cases with BRCA2 germline pathogenic mutation than those without. Patients with DRG pathogenic mutation have shorter OS than those with no-DRG pathogenic mutation, but there is no significant association between BRCA2 pathogenic mutations and OS.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"789-796"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[ALK rearranged Spitz melanocytoma: a clinicopathological and molecular genetic analysis of two cases]. [ALK重排的Spitz黑色素细胞瘤:两例病例的临床病理学和分子遗传学分析]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20240527-00340
Y Tu, W P Lu, J Wang
{"title":"[ALK rearranged Spitz melanocytoma: a clinicopathological and molecular genetic analysis of two cases].","authors":"Y Tu, W P Lu, J Wang","doi":"10.3760/cma.j.cn112151-20240527-00340","DOIUrl":"10.3760/cma.j.cn112151-20240527-00340","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinicopathological, immunohistochemical and molecular characteristics of cutaneous ALK-rearranged Spitz melanocytoma. <b>Methods:</b> Two cases of cutaneous ALK-rearranged Spitz melanocytoma from outside hospital consultations in Department of Pathology, Affiliated Cancer Hospital of Fudan University in August 2020 and in Shanghai Ackermann Medical Laboratory in June 2022 were collected. The clinicopathological features, immunophenotypes and molecular profiles of two patients with cutaneous Spitzoid melanocytic tumor harboring ALK-rearrangement were analyzed. The literatures were reviewed. <b>Results:</b> The study included an 8-year-old boy and an 11-year-old girl, who presented with a polypoid lesion in the skin of right thigh and left auricle measuring 1.0 cm and 1.2 cm, respectively. Histologically, they were composed of medium to large-sized epithelioid to plump spindle cells, arranged in nested, plexiform or fascicular patterns in the superficial dermis. The neoplastic cells had abundant eosinophilic cytoplasm with round to ovoid vesicular nuclei containing prominent eosinophilic nucleoli. One case showed mild to moderate nuclear pleomorphism and mitotic activity (average, 2/mm<sup>2</sup>). Immunohistochemically, the epithelioid and plump spindle cells showed diffuse and strong staining of S-100 protein, SOX10, and ALK (D5F3 and 1A4), but did not express HMB45, PNL2 and MiTF. ALK-rearrangement was detected by fuorescence in situ hybridization in both cases. Subsequent next generation sequence (NGS) analysis identified KANK1::ALK and TPM3:ALK fusions. At 34 and 14 months after surgical resection, both patients remained well with no signs of recurrence or metastasis. <b>Conclusions:</b> ALK-rearranged Spitz melanocytoma represents a morphologically and genetically distinct subset of Spitz melanocytoma, characterized clinically by predilection in children and adolescents, with Spitzoid morphology in plexiform pattern, positive immunohistochemical stains, and rearrangement of ALK. As some cases show atypical features and high mitotic activity, a distinction from Spitz melanoma is warranted.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"816-821"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Solitary fibrous tumor of urinary bladder with extensive epithelial inclusions: report of a case]. [伴有广泛上皮内含物的膀胱孤立性纤维瘤:一例报告]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20231105-00334
L Ye, M Zhao
{"title":"[Solitary fibrous tumor of urinary bladder with extensive epithelial inclusions: report of a case].","authors":"L Ye, M Zhao","doi":"10.3760/cma.j.cn112151-20231105-00334","DOIUrl":"10.3760/cma.j.cn112151-20231105-00334","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"864-866"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Low-grade endometrial stromal sarcoma with extensive sex cord and smooth muscle differentiation: report of a case]. [伴有广泛性索和平滑肌分化的低级别子宫内膜基质肉瘤:一例病例报告]。
中华病理学杂志 Pub Date : 2024-08-08 DOI: 10.3760/cma.j.cn112151-20240525-00336
H Y Chen, Y Hu, J J Wang, Y Q Gu
{"title":"[Low-grade endometrial stromal sarcoma with extensive sex cord and smooth muscle differentiation: report of a case].","authors":"H Y Chen, Y Hu, J J Wang, Y Q Gu","doi":"10.3760/cma.j.cn112151-20240525-00336","DOIUrl":"10.3760/cma.j.cn112151-20240525-00336","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"53 8","pages":"867-869"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信